In Vitro Characterization of Ephedrine-Related Stereoisomers at Biogenic Amine Transporters and the Receptorome Reveals Selective Actions as Norepinephrine Transporter Substrates

@article{Rothman2003InVC,
  title={In Vitro Characterization of Ephedrine-Related Stereoisomers at Biogenic Amine Transporters and the Receptorome Reveals Selective Actions as Norepinephrine Transporter Substrates},
  author={Richard B. Rothman and Nga Vu and John S. Partilla and Bryan L. Roth and Sandra J. Hufeisen and Beth A Compton-Toth and Jon Birkes and Richard Young and Richard A Glennon},
  journal={Journal of Pharmacology and Experimental Therapeutics},
  year={2003},
  volume={307},
  pages={138 - 145}
}
  • R. RothmanNga Vu R. Glennon
  • Published 1 October 2003
  • Biology, Chemistry
  • Journal of Pharmacology and Experimental Therapeutics
Ephedrine is a long-studied stimulant available both as a prescription and over-the-counter medication, as well as an ingredient in widely marketed herbal preparations, and is also used as a precursor for the illicit synthesis of methamphetamine. Ephedrine is related to phenylpropanolamine, a decongestant removed from the market place due to concerns that its use increased the risk of hemorrhagic stroke. Standard pharmacology texts emphasize that ephedrine is both a direct and indirect… 

Figures and Tables from this paper

Binding of the amphetamine-like 1-phenyl-piperazine to monoamine transporters.

It is found that 1-phenyl-piperazine analogs inhibit uptake as well as induce release in all three monoamine transporters and the selectivity of the PP analogs can be adjusted by carefully selecting substituents on the PP skeleton.

An investigation of the optical isomers of methcathinone (MCAT), and two achiral analogs, at monoamine transporters and in intracranial self- stimulation studies in rats.

It is found that the isomers of MCAT are nearly equieffective at dopamine and norepinephrine transporters as transporter substrates, and are >63-fold less potent at the serotonin transporter (SERT).

Pharmacological Effects of Ephedrine Alkaloids on Human α1- and α2-Adrenergic Receptor Subtypes

These studies have demonstrated that orientation of the β-hydroxyl group on the ethylamino side chain and the state of N-methyl substitution are important for α-AR binding and functional activity of the ephedrine alkaloids.

Neuropharmacology of Synthetic Cathinones.

Overall, the findings show that certain synthetic cathinones are powerful drugs of abuse that could pose significant risk to users.

Cellular Uptake of Psychostimulants – Are High- and Low-Affinity Organic Cation Transporters Drug Traffickers?

It is shown that several psychostimulants and hallucinogens are substrates for OCTs, including mescaline, which could be a reason for highly variable adverse reactions.

Powerful Cocaine-Like Actions of 3,4-Methylenedioxypyrovalerone (MDPV), a Principal Constituent of Psychoactive ‘Bath Salts’ Products

The data show that MDPV is a monoamine transporter blocker with increased potency and selectivity for catecholamines when compared with cocaine, and may provide a mechanism to explain the adverse effects observed in humans taking high doses of ‘bath salts’ preparations.

The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain Tissue

In vitro and in vivo methods demonstrate that designer methcathinone analogs are substrates for monoamine transporters, with a profile of transmitter-releasing activity comparable to MDMA.
...

References

SHOWING 1-10 OF 38 REFERENCES

Direct effects of ephedrine isomers on human β-adrenergic receptor subtypes

Direct effects of ephedrine isomers on human beta-adrenergic receptor subtypes.

1R,2S- ephedrine was nearly equipotent as a beta1-/beta2-AR agonist and the only isomer possessing weak partial agonist activity on beta3-AR.

3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro.

It is found that long-term MDMA use could lead to the development of fenfluramine-like VHD, and the necessity of screening current and future drugs at h5-HT2B receptors for agonist actions before their use in humans is underscored.

Discriminative Stimulus Properties of (−)Ephedrine

Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.

  • B. RothK. Baner R. Rothman
  • Biology, Psychology
    Proceedings of the National Academy of Sciences of the United States of America
  • 2002
Salvinorin A is the first naturally occurring nonnitrogenous opioid-receptor subtype-selective agonist for kappa opioid receptors, and may represent novel psychotherapeutic compounds for diseases manifested by perceptual distortions (e.g., schizophrenia, dementia, and bipolar disorders).

Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist

  • B. RothK. Baner R. Rothman
  • Biology
    Proceedings of the National Academy of Sciences of the United States of America
  • 2002
Salvinorin A is the first naturally occurring nonnitrogenous opioid-receptor subtype-selective agonist for κ opioid receptors and may represent novel psychotherapeutic compounds for diseases manifested by perceptual distortions (e.g., schizophrenia, dementia, and bipolar disorders).

Evidence for Possible Involvement of 5-HT2B Receptors in the Cardiac Valvulopathy Associated With Fenfluramine and Other Serotonergic Medications

It is suggested that all clinically available medications with serotonergic activity and their active metabolites be screened for agonist activity at 5-HT2B receptors and that clinicians should consider suspending their use of medications with significant activity at5-HT1B receptors.

Amphetamine‐type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

In vitro methods determined the neurochemical mechanism of action of amphetamine, 3,4‐methylenedioxymethamphetamine (MDMA), (+)‐methamphetamine, ephedrine, phentermine, and aminorex, and demonstrated that the most potent effect of these stimulants is to release NE.